The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study:

Pulmonary Circulation

TakayukiJujo-Sanada¹ 

关键词: anticoagulation;    major bleeding;    pulmonary vasodilators;    venous thromboembolism;    vitamin K antagonist;   

DOI  :  10.1177/2045893217717258

学科分类：医学（综合）

来源: Sage Journals

【 摘 要 】

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulation therapy. However, the bleeding risk and recurrence of venous thromboembolism (VTE) in CTEPH patients who are administered warfarin have not been adequately evaluated. The purpose of this study was to evaluate the risk of clinically relevant bleeding, recurrent VTE, and clinical worsening in patients with CTEPH who were administered warfarin.

【 授权许可】

CC BY